EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment and Outcomes of Clinical Bioprosthetic Valve Thrombosis After Surgical and Transcatheter Valve Replacement: A Narrative Review

Sunil K. Ohri

Journal of Vascular Diseases · 12.11.2026 · 5 (6) · 50

DOI: 10.3390/jvd5060050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Diseases, online erschienen am 12.11.2026. Verfasst von Sunil K. Ohri. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinically significant thrombosis of surgical and transcatheter biological valves is increasingly recognised, yet most reviews have concentrated on subclinical leaflet thrombosis after transcatheter aortic valve implantation. This narrative review examines treatment and outcomes after diagnosis of clinical bioprosthetic valve thrombosis in the aortic or mitral position, keeping asymptomatic hypoattenuated leaflet thickening separate. The evidence consists of 17 observational cohorts and case series, several of which overlap, include right-sided valves or use treatment response as part of the diagnosis; no randomised treatment trial has been reported. After anticoagulation, mainly with vitamin K antagonists, most studies reported haemodynamic improvement in most patients assessed, but endpoints and denominators varied; in one transcatheter registry, complete resolution was reported in 12 of 26 patients (46%), a figure that included two patients who were not anticoagulated. Recovery often took several months. Recurrence and bleeding estimates come mainly from one mixed-valve cohort that included right-sided prostheses: thrombosis recurred in 23% of initial responders, and major bleeding occurred in 12% of treated patients versus 2% of matched controls, an observational difference that cannot be attributed wholly to anticoagulation. Evidence for thrombolysis, redo surgery and transcatheter reintervention is limited to small series and case reports. The evidence supports confirming suspected thrombosis with transoesophageal echocardiography or four-dimensional computed tomography, starting a vitamin K antagonist in haemodynamically stable patients, referring unstable patients or those with persistent obstruction for a Heart Team decision, and individualising extended anticoagulation against bleeding risk. Direct oral anticoagulants are not established for clinical thrombosis, and the optimal duration of treatment is unknown.

Zitieren

APA

Ohri, S. K. (2026). Treatment and Outcomes of Clinical Bioprosthetic Valve Thrombosis After Surgical and Transcatheter Valve Replacement: A Narrative Review. Journal of Vascular Diseases, 5(6), 50. https://doi.org/10.3390/jvd5060050

Vancouver

Ohri SK. Treatment and Outcomes of Clinical Bioprosthetic Valve Thrombosis After Surgical and Transcatheter Valve Replacement: A Narrative Review. Journal of Vascular Diseases. 2026;5(6):50. doi:10.3390/jvd5060050

BibTeX
@article{Ohri2026,
  author = {Ohri, Sunil K.},
  title = {Treatment and Outcomes of Clinical Bioprosthetic Valve Thrombosis After Surgical and Transcatheter Valve Replacement: A Narrative Review},
  journal = {Journal of Vascular Diseases},
  year = {2026},
  volume = {5},
  number = {6},
  pages = {50},
  doi = {10.3390/jvd5060050}
}
Kostenlos starten →